Trial intelligence / Profile preview

Ketorolac vs Tramadol for Pediatric Fracture Pain

NCT00560443Phase 4Completed

Sponsor
IRCCS Burlo Garofolo
Start
Feb 2008
Primary completion
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of tramadol in pain (2 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoint: Estimation of pain reduction at 6 hours. Started Feb 2008; status: completed.

02

Drugs

tramadol
03

Conditions

pain

Beyond the preview

Go deeper on NCT00560443.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00560443.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call